P. Bingley

发表

Diabetes Antibody Standardization Program: first assay proficiency evaluation.

P. Bingley, E. Bonifacio, P. Mueller, 2003, Diabetes.

HLA Genotyping Supports a Nonautoimmune Etiology in Patients Diagnosed With Diabetes Under the Age of 6 Months

P. Bingley, A. Hattersley, S. Ellard, 2006, Diabetes.

Association of Gluten Intake During the First 5 Years of Life With Incidence of Celiac Disease Autoimmunity and Celiac Disease Among Children at Increased Risk.

P. Bingley, S. Virtanen, W. Hagopian, 2019, JAMA.

Three generations of autoimmune diabetes: an extended family study

P. Bingley, E. Gale, R. Dix, 2003, Diabetologia.

Type 1 Diabetes TrialNet: A Multifaceted Approach to Bringing Disease-Modifying Therapy to Clinical Use in Type 1 Diabetes

P. Bingley, M. Atkinson, D. Wherrett, 2018, Diabetes Care.

Use of Dried Capillary Blood Sampling for Islet Autoantibody Screening in Relatives: A Feasibility Study.

P. Bingley, C. Beam, A. Steck, 2015, Diabetes technology & therapeutics.

Effects of high-dose oral insulin on immune responses in children at high risk for type 1 diabetes: the Pre-POINT randomized clinical trial.

P. Bingley, E. Bonifacio, F. Buettner, 2015, JAMA.

Diabetes Antibody Standardization Program: evaluation of assays for autoantibodies to glutamic acid decarboxylase and islet antigen-2

Michael Schlosser, P. Bingley, E. Bonifacio, 2008, Diabetologia.

Safety of high-dose nicotinamide: a review

P. Bingley, M. Knip, F. T. E. Group, 2000, Diabetologia.

Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease

Luc J. Smink, Neil M. Walker, Linda S. Wicker, 2003, Nature.

Can We Really Predict IDDM?

P. Bingley, E. Bonifacio, E. Gale, 1993, Diabetes.

Autoimmune Type 1 Diabetes

P. Bingley, E. Gale, 2004 .

The Adolescent Cardio-Renal Intervention Trial (AdDIT): retinal vascular geometry and renal function in adolescents with type 1 diabetes

P. Bingley, D. Dunger, T. Wong, 2018, Diabetologia.

Identifying hepatic nuclear factor 1alpha mutations in children and young adults with a clinical diagnosis of type 1 diabetes.

P. Bingley, A. Hattersley, S. Ellard, 2003, Diabetes care.

Rising incidence of insulin dependent diabetes in children aged under 5 years in the Oxford region: time trend analysis

P. Bingley, E. Gale, S. Gardner, 1997, BMJ.

What is Type 1 Diabetes

P. Bingley, P. Lambert, 2002 .

Standardization of IVGTT to Predict IDDM

P. Bingley, G. Eisenbarth, P. Colman, 1992, Diabetes Care.

Nicotinamide and insulin secretion in normal subjects

P. Bingley, E. Gale, R. Bonfanti, 1993, Diabetologia.

Slow metabolic deterioration towards diabetes in islet cell antibody positive patients with autoimmune polyendocrine disease

P. Bingley, E. Bonifacio, K. Miles, 1994, Diabetologia.

Interactions of Age, Islet Cell Antibodies, Insulin Autoantibodies, and First-Phase Insulin Response in Predicting Risk of Progression to IDDM in ICA+ Relatives: The ICARUS Data Set

P. Bingley, 1996, Diabetes.

Can We Prevent IDDM?

P. Bingley, E. Gale, 1994, Diabetes Care.

Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes

Mark S. Anderson, P. Bingley, M. Knip, 2019, Diabetes Care.

Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus.

P. Bingley, E. Bonifacio, E. Gale, 1994, Lancet.

Relative predispositional effects of HLA class II DRB1-DQB1 haplotypes and genotypes on type 1 diabetes: a meta-analysis.

P. Bingley, J. Ilonen, Å. Lernmark, 2007, Tissue antigens.

Combined Analysis of Autoantibodies Improves Prediction of IDDM in Islet Cell Antibody-Positive Relatives

P. Bingley, E. Bonifacio, G. Bottazzo, 1994, Diabetes.

Autoantibodies to IA-2β improve diabetes risk assessment in high-risk relatives

P. Bingley, E. Bonifacio, A. Ziegler, 2008, Diabetologia.

Blood and Islet Phenotypes Indicate Immunological Heterogeneity in Type 1 Diabetes

P. Bingley, J. Todd, D. Dunger, 2014, Diabetes.

Reactivity to N-Terminally Truncated GAD65(96–585) Identifies GAD Autoantibodies That Are More Closely Associated With Diabetes Progression in Relatives of Patients With Type 1 Diabetes

P. Bingley, P. Achenbach, K. Gillespie, 2015, Diabetes.

Comparison of Bolus and Infusion Protocols for Determining Acute Insulin Response to Intravenous Glucose in Normal Humans

P. Bingley, P. Colman, E. Gale, 1993, Diabetes Care.

Islet autoantibody markers in IDDM: risk assessment strategies yielding high sensitivity

P. Bingley, E. Bonifacio, L. Rogge, 1995, Diabetologia.

Can Islet Cell Antibodies Predict IDDM in the General Population?

P. Bingley, E. Bonifacio, D. Dunger, 1993, Diabetes Care.

Association of intercellular adhesion molecule-1 gene with type 1 diabetes

P. Bingley, J. Todd, S. Nutland, 2003, The Lancet.

Loss of regular oscillatory insulin secretion in islet cell antibody positive non-diabetic subjects

P. Bingley, D. Matthews, E. Gale, 2004, Diabetologia.

Mortality from ischaemic heart disease in cohort of 23000 patients with insuli-treated diabetes

P. Bingley, N. Waugh, C. Patterson, 2018 .

Population based study of prevalence of islet cell autoantibodies in monozygotic and dizygotic Danish twin pairs with insulin dependent diabetes mellitus

P. Bingley, A. Green, K. Kyvik, 1997, BMJ.

Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes

A. J. Swerdlow, P. Bingley, N. Waugh, 2003, Diabetologia.

GAD autoantibodies and epitope reactivities persist after diagnosis in latent autoimmune diabetes in adults but do not predict disease progression: UKPDS 77

P. Bingley, E. Bonifacio, J. Levy, 2007, Diabetologia.

Prediction of IDDM in the General Population: Strategies Based on Combinations of Autoantibody Markers

P. Bingley, E. Bonifacio, G. Bottazzo, 1997, Diabetes.

Relationship between islet autoantibody status and the clinical characteristics of children and adults with incident type 1 diabetes in a UK cohort

P. Bingley, D. Dunger, I. Godsland, 2018, BMJ Open.

Rising Incidence of Type 1 Diabetes Is Associated With Altered Immunophenotype at Diagnosis

P. Bingley, K. Gillespie, A. E. Long, 2012, Diabetes.

Early-Onset, Coexisting Autoimmunity and Decreased HLA-Mediated Susceptibility Are the Characteristics of Diabetes in Down Syndrome

P. Bingley, T. Rohrer, R. Holl, 2013, Diabetes Care.

Predicting type 1 diabetes using autoantibodies: the latest results from the diabetes autoantibody standardization program.

P. Bingley, E. Bonifacio, P. Mueller, 2002, Diabetes technology & therapeutics.

& Type 1 Diabetes TrialNet Study Group (2016). The implications of autoantibodies to a single islet antigen in relatives with normal glucose tolerance: development of other autoantibodies and progression to type 1 diabetes. Diabetologia , (3),

P. Bingley, J. Krischer, D. Boulware, 2016 .

Attenuated humoral responses in HLA-A*24-positive individuals at risk of type 1 diabetes

P. Bingley, K. Gillespie, A. E. Long, 2015, Diabetologia.

Islet Autoantibody Testing: An End to the Trials and Tribulations?

P. Bingley, A. Williams, 2013, Diabetes.

IA-2 (islet cell antigen 512) is the primary target of humoral autoimmunity against type 1 diabetes-associated tyrosine phosphatase autoantigens.

P. Bingley, E. Bonifacio, V. Lampasona, 1998, Journal of immunology.

Undiagnosed coeliac disease at age seven: population based prospective birth cohort study

P. Bingley, Richard W Jones, A. Ness, 2004, BMJ : British Medical Journal.

Rationale and protocol for the After Diabetes Diagnosis REsearch Support System (ADDRESS): an incident and high risk type 1 diabetes UK cohort study

P. Bingley, D. Dunger, I. Godsland, 2017, BMJ Open.

Variation by age group and seasonally at diagnosis of childhood IDDM in Europe

P. Bingley, C. de Beaufort, A. Green, 1995, Diabetologia.

Epidemiology of type 1 diabetes

P. Bingley, E. Gale, 1993 .

Incidence of insulin dependent diabetes in England: a study in the Oxford region, 1985-6.

P. Bingley, E. Gale, 1989, BMJ.

Diabetes in the parents of children with Type I diabetes

P. Bingley, E. Gale, K. Gillespie, 2002, Diabetologia.

Risk of pediatric celiac disease according to HLA haplotype and country.

P. Bingley, E. Bonifacio, W. Hagopian, 2014, The New England journal of medicine.

Evaluation of a high-throughput second antibody radiobinding assay for measuring IgA antibodies to human tissue transglutaminase.

P. Bingley, D. J. Unsworth, E. Gale, 1999, Journal of immunological methods.

4 Lessons from family studies

P. Bingley, E. Gale, 1991 .

Presentation and progress of childhood diabetes mellitus: a prospective population-based study

P. Bingley, D. Dunger, J. Pinkney, 2004, Diabetologia.

Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus

P. Bingley, E. Bonifacio, M. Rowley, 1994, The Lancet.

‘Insulin autoantibody affinity measurement using a single concentration of unlabelled insulin competitor discriminates risk in relatives of patients with type 1 diabetes

P. Bingley, C. Reed, A. Williams, 2012, Clinical and experimental immunology.

Worth the wait: type 1 diabetes prospective birth cohort studies enter adolescence

P. Bingley, A. Williams, 2012, Diabetologia.

Diabetes-Specific Tyrosine Phosphatase-Like Autoantibody Epitopes of the the Islet Antigen 2 Molecule Are Major Linear Epitopes Uniquely Expressed Within Two Distinctly HLA-Associated Contiguous

P. Bingley, E. Bonifacio, A. Ziegler, 2002 .

Two Distinctly HLA-Associated Contiguous Linear Epitopes Uniquely Expressed Within the Islet Antigen 2 Molecule Are Major Autoantibody Epitopes of the Diabetes-Specific Tyrosine Phosphatase-Like Protein Autoantigens1

P. Bingley, E. Bonifacio, A. Ziegler, 2002, The Journal of Immunology.

Proinsulin-specific autoantibodies are relatively infrequent in young offspring with pre-type 1 diabetes.

P. Bingley, E. Bonifacio, A. Ziegler, 2001, Diabetes care.

Capillary whole blood measurement of islet autoantibodies.

P. Bingley, E. Bonifacio, E. Bosi, 1999, Diabetes care.

Combined analysis of IDDM-related autoantibodies in healthy schoolchildren

P. Bingley, E. Bonifacio, G. Bottazzo, 1994, The Lancet.

GAD65 autoantibody titres at diagnosis in Latent Autoimmune Diabetes in Adults (LADA) differ from Type 1 diabetes (T1D) and together with epitope specificity predict insulin requirement

P. Bingley, E. Bonifacio, J. Levy, 2004 .

Optimized autoantibody-based risk assessment in family members. Implications for future intervention trials.

P. Bingley, E. Gale, A. Williams, 1999, Diabetes care.

HLA class II typing of whole genome amplified mouth swab DNA.

P. Bingley, J. Todd, D. Middleton, 2000, Tissue antigens.

Interactions of age, islet cell antibodies, insulin autoantibodies, and first-phase insulin response in predicting risk of progression to IDDM in ICA+ relatives: the ICARUS data set. Islet Cell Antibody Register Users Study.

P. Bingley, 1996 .

Phosphatase Autoantigens Type 1 Diabetes-Associated Tyrosine Target of Humoral Autoimmunity Against IA-2 (Islet Cell Antigen 512) Is the Primary

P. Bingley, E. Bonifacio, V. Lampasona, 1998 .

The epidemiology of childhood onset diabetes: A review

P. Bingley, E. Gale, 1990 .

TIME TRENDS IN JUVENILE-ONSET DIABETES

P. Bingley, N. Waugh, A. Burden, 1988, The Lancet.

Beta cell function and ongoing autoimmunity in long-standing, childhood onset type 1 diabetes

P. Bingley, A. Hattersley, F. Wong, 2016, Diabetologia.

Islet Autoimmunity in Children With Down’s Syndrome

P. Bingley, E. Gale, J. Shield, 2006, Diabetes.

Is puberty an accelerator of type 1 diabetes in IL6-174CC females?

P. Bingley, T. Mandrup-Poulsen, O. Kristiansen, 2005, Diabetes.

Restriction fragment length polymorphism analysis of HLA haplotypes in families with type I diabetes mellitus.

P. Bingley, K. Badenhoop, E. Gale, 1990, Tissue antigens.

Soluble L‐selectin levels in type I diabetes mellitus: a surrogate marker fordisease activity?

P. Bingley, A. Krętowski, K. Gillespie, 2000, Immunology.

The Core Cysteines, (C909) of Islet Antigen-2 and (C945) of Islet Antigen-2β, Are Crucial to Autoantibody Binding in Type 1 Diabetes

P. Bingley, D. Shoemark, K. Elvers, 2012, Diabetes.

Reanalysis of twin studies suggests that diabetes is mainly genetic

P. Bingley, M. Redondo, K. Kyvik, 2001, BMJ : British Medical Journal.

Harmonization of glutamic acid decarboxylase and islet antigen-2 autoantibody assays for national institute of diabetes and digestive and kidney diseases consortia.

P. Bingley, E. Bonifacio, P. Mueller, 2010, The Journal of clinical endocrinology and metabolism.

The β-cell specific T-lymphocyte response has a distinct inflammatory phenotype in juvenile compared to adult type 1 diabetes

P. Bingley, J. Todd, D. Dunger, 2017 .

The role of autoantibodies to zinc transporter 8 in prediction of type 1 diabetes in relatives: lessons from the European Nicotinamide Diabetes Intervention Trial (ENDIT) cohort.

P. Bingley, A. E. Long, A. Williams, 2012, The Journal of clinical endocrinology and metabolism.

Update on Major Trials for the Prevention of Type I Diabetes Mellitus: The American Diabetes Prevention Trial (DPT-1) and the European Nicotinamide Diabetes Intervention Trial (ENDIT)

P. Bingley, D. Schatz, Desmond A. Schatz, 2001, Journal of pediatric endocrinology & metabolism : JPEM.

Progression to diabetes in relatives with islet autoantibodies. Is it inevitable?

P. Bingley, K. Lawrence, E. Gale, 1999, Diabetes care.

The high prevalence of autoantibodies to tissue transglutaminase in first-degree relatives of patients with type 1 diabetes is not associated with islet autoimmunity.

P. Bingley, D. J. Unsworth, E. Gale, 2001, Diabetes care.

TNF‐alpha GENE POLYMORPHISMS: ASSOCIATION WITH TYPE I (INSULIN‐DEPENDENT) DIABETES MELLITUS

P. Bingley, K. Usadel, K. Badenhoop, 1989, Journal of immunogenetics.

Anti-BSA antibodies are a major cause of non-specific binding in insulin autoantibody radiobinding assays.

P. Bingley, A. Williams, S. Rokni, 2010, Journal of immunological methods.

Trends in childhood type 1 diabetes incidence in Europe during 1989–2008: evidence of non-uniformity over time in rates of increase

P. Bingley, A. Green, U. Rothe, 2012, Diabetologia.

Symposium: diabetes mellitusThe epidemiology of childhood diabetes

P. Bingley, A. E. Long, 2013 .

Early T-cell defects in pre-type 1 diabetes

P. Bingley, E. Bonifacio, M. Lowdell, 2004, Acta Diabetologica.

Genome-Wide Association Analysis of Autoantibody Positivity in Type 1 Diabetes Cases

John A. Todd, Chris Wallace, Vincent Plagnol, 2011, PLoS genetics.

A comparison of the prevalence of islet autoantibodies in children from two countries with differing incidence of diabetes

P. Bingley, E. Gale, A. Williams, 2001, Diabetologia.

Eczema and Type 1 diabetes

P. Bingley, E. Gale, N. Leech, 2002, Diabetic medicine : a journal of the British Diabetic Association.

Children with type-1 diabetes and their unaffected siblings have few er symptoms of asthma

P. Bingley, E. Gale, N. Leech, 1999, The Lancet.

Family studies of insulin-dependent diabetes: the UK experience.

P. Bingley, E. Gale, A. Tarn, 1988, Advances in experimental medicine and biology.

Systematic Assessment of Etiology in Adults With a Clinical Diagnosis of Young-Onset Type 2 Diabetes Is a Successful Strategy for Identifying Maturity-Onset Diabetes of the Young

M. McCarthy, P. Bingley, A. Farmer, 2012, Diabetes Care.

Maternal microchimerism in peripheral blood in type 1 diabetes and pancreatic islet β cell microchimerism

P. Bingley, W. Leisenring, E. Gale, 2007, Proceedings of the National Academy of Sciences.

P. Bingley, E. Bonifacio, J. Ilonen, 2019, Scientific Reports.

Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop.

P. Bingley, E. Bonifacio, G. Eisenbarth, 1998, Diabetes.

Islet autoantibodies and their use in predicting insulin-dependent diabetes

P. Bingley, E. Bonifacio, 1997, Acta Diabetologica.

Absolute risk of childhood-onset type 1 diabetes defined by human leukocyte antigen class II genotype: a population-based study in the United Kingdom.

Heather J Cordell, Glenys Thomson, John A Todd, 2004, The Journal of clinical endocrinology and metabolism.

Combined testing of antibody titer and affinity improves insulin autoantibody measurement: Diabetes Antibody Standardization Program.

P. Bingley, E. Bonifacio, P. Mueller, 2007, Clinical immunology.

IGF‐secreting tumour treated with a combination of growth hormone and glucocorticoids

P. Bingley, P. Narendran, A. Au-Yeung, 2006, Clinical endocrinology.

An association analysis of the HLA gene region in latent autoimmune diabetes in adults

E. Zeggini, P. Bingley, J. Levy, 2006, Diabetologia.

Low interleukin-2 receptor levels in serum of patients with insulin-dependent diabetes

P. Bingley, E. Bonifacio, S. Genovese, 1994, The clinical investigator.

A novel micro-assay for insulin autoantibodies.

P. Bingley, E. Bonifacio, J. Palmer, 1997, Journal of autoimmunity.

An increased frequency of NK cell receptor and HLA-C group 1 combinations in early-onset type 1 diabetes

P. Bingley, F. Wong, G. Gill, 2011, Diabetologia.

Dynamic changes in immune gene co-expression networks predict development of type 1 diabetes

P. Bingley, E. Bonifacio, J. Ilonen, 2021, Scientific Reports.

Progression to type 1 diabetes in islet cell antibody-positive relatives in the European Nicotinamide Diabetes Intervention Trial: the role of additional immune, genetic and metabolic markers of risk

P. Bingley, E. Gale, T. T. 1. D. T. S. Group, 2006, Diabetologia.

POLYMORPHISMS : ASSOCIATION MELLITUS WITH TYPE I ( INSULIN-DEPENDENT ) DIABETES IS

P. Bingley, K. Usadel, K. Badenhoop, 2007 .

Early Onset of Diabetes in the Proband Is the Major Determinant of Risk in HLA DR3-DQ2/DR4-DQ8 Siblings

P. Bingley, K. Gillespie, A. Williams, 2014, Diabetes.

High familial risk and genetic susceptibility in early onset childhood diabetes.

P. Bingley, E. Gale, K. Gillespie, 2002, Diabetes.

Family studies and the causes of insulin-dependent diabetes

P. Bingley, E. Gale, 1993 .

Zinc Transporter-8 Autoantibodies Improve Prediction of Type 1 Diabetes in Relatives Positive for the Standard Biochemical Autoantibodies

P. Bingley, J. Krischer, C. Beam, 2012, Diabetes Care.

Insulin autoantibodies: more specific than proinsulin autoantibodies for prediction of type 1 diabetes.

P. Bingley, R. Chance, E. Gale, 1999, Journal of autoimmunity.

Author Correction: A combined risk score enhances prediction of type 1 diabetes among susceptible children

Lauric A. Ferrat, P. Bingley, E. Bonifacio, 2020, Nature Medicine.

Children’s erythrocyte fatty acids are associated with the risk of islet autoimmunity

Nikita A. Sakhanenko, P. Bingley, E. Bonifacio, 2021, Scientific Reports.

A combined risk score enhances prediction of type 1 diabetes among susceptible children

Lauric A. Ferrat, P. Bingley, E. Bonifacio, 2020, Nature Medicine.

Diseases Consortia Autoantibody Assays for National Institute of Diabetes and Digestive and Kidney Harmonization of Glutamic Acid Decarboxylase and Islet Antigen-2

P. Bingley, E. Bonifacio, P. Mueller, 2010 .

Influence of maternal age at delivery and birth order on risk of type 1 diabetes in childhood: prospective population based family study

P. Bingley, C. Rogers, E. Gale, 2000, BMJ : British Medical Journal.

Stratification of type 1 diabetes risk on the basis of islet autoantibody characteristics.

P. Bingley, E. Bonifacio, A. Ziegler, 2004, Diabetes.

Diabetes Antibody Standardization Program: evaluation of assays for insulin autoantibodies

P. Bingley, E. Bonifacio, P. Mueller, 2010, Diabetologia.

Diabetes Antibody Standardization Program

P. Bingley, P. Mueller, P. Achenbach, 2011, Diabetes Care.

Cerebellar ataxia, peripheral neuropathy, "gluten sensitivity" and anti-neuronal autoantibodies.

P. Bingley, D. J. Unsworth, A. Wills, 2006, Clinical laboratory.

Trends and cyclical variation in the incidence of childhood type 1 diabetes in 26 European centres in the 25 year period 1989–2013: a multicentre prospective registration study

P. Bingley, A. Green, N. Bratina, 2018, Diabetologia.

35th Annual meeting of the European Association for the Study of Diabetes. Brussels, Belgium, 28 September-2 October, 1999. Abstracts.

Thomas J. Smith, B. M. Rasmussen, V. C. Phan, 1999, Diabetologia.

Impact of Age and Antibody Type on Progression From Single to Multiple Autoantibodies in Type 1 Diabetes Relatives

P. Bingley, A. Steck, D. Boulware, 2017, The Journal of clinical endocrinology and metabolism.

The implications of autoantibodies to a single islet antigen in relatives with normal glucose tolerance: development of other autoantibodies and progression to type 1 diabetes

P. Bingley, J. Krischer, D. Boulware, 2015, Diabetologia.

Clinical applications of diabetes antibody testing.

P. Bingley, 2010, The Journal of clinical endocrinology and metabolism.

First evaluation of assays for autoantibodies to IA-2b

P. Bingley, P. Mueller, P. Achenbach, 2011 .

Type 1 diabetes risk assessment: improvement by follow-up measurements in young islet autoantibody-positive relatives

P. Bingley, E. Bonifacio, A. Ziegler, 2006, Diabetologia.

The TrialNet Natural History Study of the Development of Type 1 Diabetes: objectives, design, and initial results

P. Bingley, E. Bonifacio, J. Lachin, 2009, Pediatric diabetes.

The prevalence of insulin autoantibodies at the onset of Type 1 diabetes is higher in males than females during adolescence

P. Bingley, E. Gale, R. Dix, 2003, Diabetologia.

Islet autoantibodies, nationality and gender: a multinational screening study in first-degree relatives of patients with Type I diabetes

P. Bingley, A. T. N. Group, E. Gale, 2002, Diabetologia.

The Effect of Ethnicity in the Rate of Beta Cell Functional Loss in the First 3 Years After Type 1 Diabetes Diagnosis.

Kathleen C. Fraser, Mark S. Anderson, Renee A. Davis, 2020, The Journal of clinical endocrinology and metabolism.

The rising incidence of childhood type 1 diabetes and reduced contribution of high-risk HLA haplotypes

P. Bingley, S. Bain, A. Barnett, 2004, The Lancet.

Evidence That HLA Class I and II Associations With Type 1 Diabetes, Autoantibodies to GAD and Autoantibodies to IA-2, Are Distinct

P. Bingley, J. Todd, H. Stevens, 2011, Diabetes.

Autoantibodies to islet antigen-2 are associated with HLA-DRB1*07 and DRB1*09 haplotypes as well as DRB1*04 at onset of type 1 diabetes: the possible role of HLA-DQA in autoimmunity to IA-2

P. Bingley, K. Gillespie, A. Williams, 2008, Diabetologia.

Proposed guidelines on screening for risk of type 1 diabetes.

P. Bingley, E. Bonifacio, A. Ziegler, 2001, Diabetes Care.

β-Cell–Specific CD8 T Cell Phenotype in Type 1 Diabetes Reflects Chronic Autoantigen Exposure

Katherine K. Matthews, P. Bingley, S. Heck, 2014, Diabetes.

Maternal age and risk of type 1 diabetes in children [4] (multiple letters)

P. Bingley, A. Gunn, G. Dahlquist, 2001 .

Non-specific binding to protein A Sepharose and protein G Sepharose in insulin autoantibody assays may be reduced by pre-treatment with glycine or ethanolamine.

P. Bingley, A. Williams, A. Norcross, 2006, Journal of immunological methods.

Seasonal variation in month of diagnosis in children with type 1 diabetes registered in 23 European centers during 1989–2008: little short‐term influence of sunshine hours or average temperature

P. Bingley, A. Green, U. Rothe, 2015, Pediatric diabetes.

Diabetes mellitus among young adults in Sri Lanka—role of GAD antibodies in classification and treatment: The Sri Lanka Young Diabetes study

P. Bingley, D. Matthews, P. Katulanda, 2008, Diabetologia.

The British Diabetic Association Cohort Study, I: all‐cause mortality in patients with insulin‐treated diabetes mellitus

J L Botha, H Keen, P. Bingley, 1999, Diabetic medicine : a journal of the British Diabetic Association.

Perspectives in Diabetes Can We Really Predict IDDM

P. Bingley, 1993 .

Humoral Responses to Islet Antigen-2 and Zinc Transporter 8 Are Attenuated in Patients Carrying HLA-A*24 Alleles at the Onset of Type 1 Diabetes

P. Bingley, K. Gillespie, A. Williams, 2013, Diabetes.

Novel Association Between Immune-Mediated Susceptibility Loci and Persistent Autoantibody Positivity in Type 1 Diabetes

P. Bingley, Wei-Min Chen, F. Pociot, 2015, Diabetes.

Validation of Autoantibody Assays in Type 1 Diabetes: Workshop Programme

P. Bingley, A. Williams, 2004, Autoimmunity.

Evaluating T cell responses prior to the onset of type 1 diabetes

P. Bingley, M. Peakman, Yuk-Fun Liu, 2022, Diabetic medicine : a journal of the British Diabetic Association.

Prevention of type 1 diabetes.

P. Bingley, P. Bingley, S. Thrower, 2011, British medical bulletin.

Azide and Tween-20 reduce binding to autoantibody epitopes of islet antigen-2; implications for assay performance and reproducibility.

P. Bingley, E. Bonifacio, B. Akolkar, 2009, Journal of immunological methods.

Trends in childhood type 1 diabetes incidence in Europe during 1989–2008: evidence of non-uniformity over time in rates of increase

P. Bingley, A. Green, U. Rothe, 2012, Diabetologia.

Trends and cyclical variation in the incidence of childhood type 1 diabetes in 26 European centres in the 25 year period 1989–2013: a multicentre prospective registration study

P. Bingley, A. Green, N. Bratina, 2018, Diabetologia.

Mortality of South Asian patients with insulin‐treated diabetes mellitus in the United Kingdom: a cohort study

P. Bingley, N. Waugh, A. Swerdlow, 2004, Diabetic medicine : a journal of the British Diabetic Association.

Measurement of islet cell antibodies in the Type 1 Diabetes Genetics Consortium: efforts to harmonize procedures among the laboratories

P. Bingley, B. Akolkar, L. Perdue, 2010, Clinical trials.

Risk of pediatric celiac disease according to HLA haplotype and country

P. Bingley, E. Bonifacio, W. Hagopian, 2014, Indian Pediatrics.

Islet autoantibodies can discriminate maturity‐onset diabetes of the young (MODY) from Type 1 diabetes

P. Bingley, B. Shields, A. Hattersley, 2011, Diabetic medicine : a journal of the British Diabetic Association.